More on CADL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-166.7% Growth)
- Ratings (9.2 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Candel Therapeutics (NQ:CADL)
Delayed: 9.40 -0.28 (2.89%)
Prev. Close $9.68  
Open$9.81 
52 Wk High$ 
52 Wk Low$ 
Day High$9.85 
Day Low$9.16 
P/E N/A  
EPS$ 
Volume1,441,344 

Friends, Peers and Foes (?): TRIN (more...)

Jul 29, 2026 08:05 AM Candel Therapeutics to Present at Canaccord Genuity’s 46th Annual Growth Conference in Boston
Jul 29, 2026 06:52 AM H.C. Wainwright Reiterates Buy Rating on Candel Therapeutics Inc. (CADL)
Jul 27, 2026 04:28 PM Form SCHEDULE 13G Candel Therapeutics, Filed by: BlackRock, Inc.
Jul 13, 2026 02:13 AM Stifel Starts Candel Therapeutics Inc. (CADL) at Buy
Jul 8, 2026 04:13 PM Form 4 Candel Therapeutics, For: Jul 06 Filed by: Sims Mark E.
Jul 8, 2026 04:11 PM Form 3 Candel Therapeutics, For: Jul 06 Filed by: Sims Mark E.
Jul 8, 2026 04:05 PM Candel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jul 1, 2026 04:23 PM Form 4 Candel Therapeutics, For: Jun 29 Filed by: Barone Francesca
Jul 1, 2026 04:22 PM Form 4 Candel Therapeutics, For: Jun 29 Filed by: Tyagarajan Seshu
Jul 1, 2026 04:21 PM Form 4 Candel Therapeutics, For: Jun 30 Filed by: Manning Paul B
View All Articles

Entities mentioned with CADL

View All Entities